News & Updates
Filter by Specialty:
Show Multimedia Only
Romosozumab prevents new vertebral fractures in postmenopausal women with osteoporosis
29 Sep 2021
byJairia Dela Cruz
Twelve months of treatment with romosozumab produce marked reductions in new vertebral fractures, especially moderate-to-severe fractures, among postmenopausal women with osteoporosis, according to a study.
Romosozumab prevents new vertebral fractures in postmenopausal women with osteoporosis
29 Sep 2021
Tofacitinib may promote HBV reactivation in certain RA patients
24 Sep 2021
Use of tofacitinib for rheumatoid arthritis (RA) may lead to reactivation of hepatitis B virus (HBV), especially among hepatitis B surface antigen-positive (HBsAg+) and HBsAg-negative/hepatitis B core antibody-positive (HBsAg–/HBcAb+) patients, according to a study from Taiwan.
